Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Boehringer-Ingelheim Pharmaceuticals, Inc.
Current Parent CompanyBoehringer Ingelheim
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $95,000,000
Year: 2012
Date: October 25, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: kickbacks and bribery
Mega-ScandalImproper Drug Marketing
Violation Description: Boehringer-Ingelheim Pharmaceuticals, Inc. agreed to pay $95 million to resolve multistate litigation alleging that it marketed the drugs Aggrenox, Atrovent, Combivent and Micardis for uses not approved by the FDA and paid kickbacks to medical professionals. Also involved in the settlement was the federal government, which issued its own announcement; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Germany
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.